| ADGLYSS Eli Lilly and Company
2098492 08 Apr 2021 | on 18 Oct 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, osteoarthritis, pain relief, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; vascular diseases; Diagnostic agents, preparations and substances for medical diagnostic purposes; diagnostic scanning agents for medical use, namely, diagnostic scanning agents for in vivo use; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases. | | | adglow (word and device in colors) ADGLOW CORP, S.L.
1963514 16 May 2019 | on 31 Dec 1969 | Class 035 Class 035 Advertising, Business & Retail Services Provision of advertising space, time and media on the internet; Rental of advertising space on the internet; Providing marketing consulting in the field of social media on the internet; Business advice relating to strategic marketing on the internet; Updating of advertising information on a computer data base in relation to online marketing and advertisement services; Market research in the field of online marketing and advertising; providing information regarding advertising, marketing and promotional services for others to businesses; Statistical analysis and reporting about Internet traffic and marketing on line; Analysis of company behavior on the internet; Assistance, advisory services and consultancy with regard to business analysis on the internet; Search engine optimization on the internet; Search engine marketing services on the internet. | | | ADGLOW H.J. CHAPMAN & COMPANY
(ADGLOW) LIMITED
237533 24 Sep 1956 | on 26 May 1989 | Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Class 016 Class 016 Paper Goods and Printed Material Printed or photographic reproductions (prints) for viewing by direct light or light transmitted from the rear and lamps and lamp housings or boxes for use in the display and illumination from the rear of such light transmitting printed or photographic reproductions. | |